A clinical approach to reveal mechanism and treatment of steroid induced diabetes

A clinical approach to reveal mechanism and treatment of glucocorticoid induced diabetes - A clinical approach to reveal mechanism and treatment of glucocorticoid induced diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000037040

Enrollment

Registered

2019-07-01

Start date

2019-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Treatment with GLP-1

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed as needing 5 mg/dL - 15 mg/dL predonisolone treatment.

Exclusion criteria

Exclusion criteria: Patients who are allergic to the target drug

Design outcomes

Primary

Measure	Time frame
measurement of HbA1c, glucose, IRI, glucagon, GLP-1, HOMA-R before and 3~6 months after the treatment of glucocorticoids.	—

Countries

Japan

Contacts

Public ContactRieko Goto

Kumamoto University Hospital Metabolic Medicine

boots0gt@gmail.com096-373-5169

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026